Inventiva
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inventiva and buy or sell other stocks, ETFs, and their options commission-free!About IVA
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors.
CEOAndrew Obenshain
CEOAndrew Obenshain
Employees119
Employees119
HeadquartersDaix, Bourgogne-Franche-Comte
HeadquartersDaix, Bourgogne-Franche-Comte
Founded2011
Founded2011
Employees119
Employees119
IVA Key Statistics
Market cap857.56M
Market cap857.56M
Price-Earnings ratio-1.09
Price-Earnings ratio-1.09
Dividend yield—
Dividend yield—
Average volume202.00K
Average volume202.00K
High today$4.60
High today$4.60
Low today$4.46
Low today$4.46
Open price$4.52
Open price$4.52
Volume186.18K
Volume186.18K
52 Week high$7.98
52 Week high$7.98
52 Week low$2.11
52 Week low$2.11
Stock Snapshot
The current Inventiva(IVA) stock price is $4.46, with a market capitalization of 857.56M. The stock trades at a price-to-earnings (P/E) ratio of -1.09.
During the trading session on 2025-12-14, Inventiva(IVA) shares reached a daily high of $4.60 and a low of $4.46. At a current price of $4.46, the stock is 0.0% higher than the low and still -3.0% under the high.
Trading activity shows a volume of 186.18K, compared to an average daily volume of 202K.
The stock's 52-week range extends from a low of $2.11 to a high of $7.98.
The stock's 52-week range extends from a low of $2.11 to a high of $7.98.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%